Enzolytics Inc (ENZC)

[FrankMD]

#BGEN has a well-defined IP portfolio aligned with a licensing strategy. Our #monoclonalantibodies, both IgG and IgA, being universal, broadly neutralizing, durable, and unaffected by mutations, are critical solutions for COVID-19 mutations. The Company aims to collaborate, license, or partner with pharma entities for 19 viruses in our repetoire for diagnostics, therapeutics, and vaccines. #SAGA #SPAC will make this possible.
@BiogenysisInc
https://accesswire.com/776544/Biogenysis-International-Patent-Application-Covering-Its-Anti-SARS-CoV-2-Monoclonal-Antibodies-Advances-to-Prosecution-in-Europe-and-as-a-US-National-Stage-Application
#SARSCOV2 #nasal #patent #AI #PCT #sciencealwayswins

#BGEN has a well-defined IP portfolio aligned with a licensing strategy. Our #monoclonalantibodies, both IgG and IgA, being universal, broadly neutralizing, durable, and unaffected by mutations, are critical solutions for COVID-19 mutations. The Company aims to collaborate,…

— Gaurav Chandra M.D. (@drgauravchandra) August 24, 2023